Skip to main content
OpenTrials
Completed

NCT Number: NCT00901472

Sleep Disordered Breathing and Diabetes

The hypothesis of this study is: sleep disordered breathing (SDB), specifically, obstructive sleep apnea, is associated with poorer glucose in the existing type 2 diabetic condition.

In an exploration of this hypothesis, the investigators hope to provide evidence linking SDB to increased severity of disease in the type 2 diabetic patient. By doing so, the investigators ultimately seek to support investigating the use of SDB interventions as an additional method of care in the treatment of type 2 diabetes.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • adult female and male patients with type 2 diabetes who are followed by University of Chicago physicians

Exclusion criteria

  • patients with the diagnosis of type 1 diabetes (DM); newly diagnosed Type 2 DM patients
  • patients with the diagnosis of OSA using CPAP for either 4 or more hours per night or 5 nights per week

Treatment and study plan

Primary outcomes

  1. Improvement in glucose tolerance

    Time frame: Day 1 to day 10.

Sponsors and collaborators

Lead sponsor

University of Chicago

Other

Registry information

Official study title

Sleep Disordered Breathing and Blood Glucose Control in Type 2 Diabetes

Important dates

Study start
2007
Primary completion
2008
Study completion
2009
First posted
May 13, 2009
Registry last updated
Sep 5, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.